KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Treasury Shares (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Treasury Shares for 15 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 8.8% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 8.8% year-over-year, with the annual reading at $1.5 million for FY2025, 8.8% up from the prior year.
  • Treasury Shares for Q4 2025 was $1.5 million at Halozyme Therapeutics, up from $1.4 million in the prior quarter.
  • The five-year high for Treasury Shares was $19.1 million in Q2 2024, with the low at $242555.0 in Q4 2023.
  • Average Treasury Shares over 5 years is $5.1 million, with a median of $4.0 million recorded in 2021.
  • The sharpest move saw Treasury Shares soared 1074.93% in 2021, then crashed 94.61% in 2023.
  • Over 5 years, Treasury Shares stood at $3.9 million in 2021, then grew by 15.38% to $4.5 million in 2022, then plummeted by 94.61% to $242555.0 in 2023, then skyrocketed by 476.68% to $1.4 million in 2024, then grew by 8.8% to $1.5 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $1.5 million, $1.4 million, and $19.1 million for Q4 2025, Q4 2024, and Q2 2024 respectively.